-
About
- Health
-
Patient Care
I Want To...
-
Research
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
-
School of Medicine
I Want to...
Ciccarone Articles
Ciccarone Center Research
-
View by Topic
- Antiplatelet Therapy
- Arrhythmias
- ASCVD (Atherosclerotic Cardiovascular Disease)
- Blood Pressure
- Cardiac CT
- Cardiovascular Risk Assessment
- Carotid Atherosclerosis
- Cerebrovascular Disease / Stroke / Cognitive Function
- Cholesterol / Lipids / Statins
- Cigarette Smoking
- Diabetes & Metabolic Syndrome
- Diet & Weight
- Disparities in Care
- Emotional Health
- Endothelial Function
- Erectile Dysfunction
- Exercise and Physical Fitness
- Family History of CVD
- Gender / Cardiovascular Disease in Women
- Genetics
- Heart Failure
- Heart Rate
- HIV
- Hormones
- Inflammation
- Markers of Thrombosis, Myocardial Injury, Wall Stress
- Mobile Health
- Nutrition, Vitamins, Supplements
- PVD – Peripheral Vascular Disease
- Quality of Care
- Renal Disease
- Rheumatoid Arthritis & Collagen Vascular Diseases
- Sleep Disorders
- Stem Cells
- Subclinical Atherosclerosis
- Uncategorized
- Vascular Imaging
- Vascular Stiffness
-
View by Journal
- American Heart Journal
- American Journal of Cardiology
- American Journal of Epidemiology
- American Journal of Hypertension
- Annals of Internal Medicine
- Arteriosclerosis, Thrombosis & Vascular Biology
- Atherosclerosis
- British Medical Journal
- Circulation
- Clinical Cardiology
- Diabetes Care
- European Heart Journal
- European Journal of Preventive Cardiology
- Heart
- Hypertension
- International Journal of Cardiology
- Journal of Hypertension
- Journal of the American College of Cardiology
- Journal of the American Heart Association
- Journal of the American Medical Association
- Mayo Clinic Proceedings
- New England Journal of Medicine
- PLoS One
-
View by Year
- Meet the Authors
Topic
Diabetes & Metabolic Syndrome
Landmark Articles
-
To facilitate the guideline-based implementation of treatment recommendations in the ambulatory setting and to encourage participation in the multiple preventive health efforts that exist, we have organized several recent guideline updates into a simple ABCDEF approach. We would remind clinicians that evidence-based medicine is meant to inform recommendations but that synthesis of patient-specific data and use of appropriate clinical judgment in each individual situation is ultimately preferred.
Published in: Journal of the American Heart AssociationRead on Pubmed -
We conclude that CAC can help risk stratify individuals with diabetes and may aid in selection of patients who may benefit from therapies such as low-dose aspirin for primary prevention of CVD. Published in: Diabetes CareRead on Pubmed -
The goal of this study was to assess the independent and collective associations of hepatic steatosis, obesity, and the metabolic syndrome with elevated hsCRP levels. We evaluated 2,388 individuals without clinical cardiovascular disease between December 2004 and December 2006. Hepatic steatosis was diagnosed by ultrasound, and the metabolic syndrome was defined using National Heart, Lung, and Blood Institute criteria. We concluded that hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased odds of high hsCRP levels. Published in: Arteriosclerosis, Thrombosis & Vascular BiologyRead on Pubmed
Insulin requirements in non-critically ill hospitalized diabetic patients with steroid-induced hyperglycemia.
Noncritically ill patients with hyperglycemia receiving steroids require a higher percentage of TDD insulin therapy as nutritional insulin to achieve normoglycemia.
- Year: 2014
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS
Type 2 diabetes and cardiovascular disease: what next?
CVD in Type 2 diabetes is multifactorial and requires a multifaceted approach in reducing known cardiovascular risks, at both the individual patient and societal levels.
- Year: 2014
- Topics: Diabetes & Metabolic Syndrome, Emotional Health
- Read more articles by: Sherita Golden, MD, MHS
Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia.
Noncritically ill patients with hyperglycemia receiving steroids require a higher percentage of total daily dose insulin therapy as nutritional insulin to achieve normoglycemia.
- Year: 2014
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS
Impact of a pharmacy-based glucose management program on glycemic control in an inpatient general medicine population.
This study found no global benefit of the pharmacy-based glucose management program for improving blood glucose values compared with usual care.
- Year: 2014
- Topics: Diabetes & Metabolic Syndrome, Quality of Care
- Read more articles by: Sherita Golden, MD, MHS
Cardiac complications of obesity.
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome, Diet & Weight
- Read more articles by: Roger S. Blumenthal, MD, M. Dominique Ashen, CRNP, PhD
Race/ethnic difference in diabetes and diabetic complications.
This study's data provide novel updates on race/ethnic differences in children and adults with type 1 diabetes, children with type 2 diabetes, and in Latino subpopulations.
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS
Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care.
- Journal: Diabetes Care
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS
High-priority research needs for insulin delivery and glucose monitoring methods.
This article summarizes future research needs in the area of technologies for insulin delivery and glucose monitoring methods.
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS
A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
Considerable evidence supports the association of nonalcoholic fatty liver disease with subclinical atherosclerosis, independent of traditional risk factors and metabolic syndrome.
- Journal: Atherosclerosis
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome, Diet & Weight, Vascular Imaging
- Read more articles by: Michael Blaha, MD, MPH, Khurram Nasir, MD, MPH
Validity of meta-analysis in diabetes: meta-analysis is an indispensable tool in evidence synthesis.
This article presents supporting arguments to support the use for meta-analysis in diabetes clinical research in a pro-con debate.
- Journal: Diabetes Care
- Year: 2013
- Topics: Diabetes & Metabolic Syndrome
- Read more articles by: Sherita Golden, MD, MHS